Advanced Freeze Dryer

The contract involves the acquisition of an advanced freeze dryer (lyophilizer) to support the Food and Drug Administration’s lyophilization research efforts, which are critical in the manufacturing of approximately 70% of FDA-approved antibiotics and most injectable drugs. This equipment will facilitate complex generics, biologics, and essential medicine manufacturing and product quality research. Featuring advanced process monitoring and control capabilities, the lyophilizer will enhance the FDA’s ability to assess manufacturing quality, support regulatory standards development, and ensure the safety, efficacy, and quality of lyophilized drug products reaching patients. The procurement is forecasted under NAICS code 333415 and will be managed by the FDA, with contacts including the Cder Acquisition Liaison and a contracting officer to be determined. The equipment acquisition aims to advance science-based regulatory oversight and improve staff training, facility inspections, and guidance development relating to lyophilized drugs, thereby strengthening the regulatory framework and supporting public health.